Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Prince Kumar Singh has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Plant-Derived Bioactive Compounds in Chronic Obstructive Pulmonary Disease: Targeting Oxidative Stress and Inflammatory Signaling

    by Saurabh Kumar, Osaid Masood, Shama Parveen, Prince Kumar Singh, Monisha Banerjee

    Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation arising from chronic inflammation, oxidative stress, mucus hypersecretion, protease–antiprotease imbalance, airway remodelling, and emphysematous destruction. This review evaluates plant-derived bioactive compounds with reported activity against molecular processes implicated in COPD. Resveratrol, kaempferol, quercetin, fisetin, epigallocatechin gallate, gallic acid, ursolic acid, hesperidin, apigenin, and luteolin are examined with emphasis on Nrf2, NF-κB, MAPKs, PI3K/Akt, SIRT1, TLR4, and NLRP3 signalling. In selected cellular and animal models, these compounds have been reported to reduce oxidative stress, inflammatory mediator release, mucus production, metalloproteinase activity, and tissue injury. However, these experimental findings do not establish therapeutic efficacy in patients with COPD. Some also affect autophagy, corticosteroid sensitivity, and pathways associated with cellular senescence. Overall, the evidence is derived mainly from cultured cells and animal models, with limited clinical data. Poor oral bioavailability, rapid metabolism, uncertain pulmonary exposure, formulation variability, dose standardisation, and potential drug interactions remain major translational limitations. Future studies should define pharmacokinetics, lung tissue exposure, optimal formulations, safety, and interactions with standard COPD therapies, followed by adequately powered clinical trials assessing exacerbations, lung function, symptoms, exercise capacity, quality of life, and treatment-related adverse effects in well-defined COPD populations.

  • Open Access

    Autophagic Flux Bottlenecks in Neurodegenerative Disease: From Cell-Specific Failure to Defect-Directed Therapy

    by Kamini Shivhare, Tripti Nair, Saurabh Shrivastva, Prince Kumar Singh

    Autophagic dysfunction is a recurrent feature of neurodegenerative disease, but increased pathway activity does not necessarily indicate effective cargo clearance. This review examines autophagic flux as a multistep quality-control process in which cargo recognition, autophagosome formation, intracellular transport, lysosomal fusion, degradation, and metabolite recovery must remain functionally coupled. We discuss how bottlenecks at different stages generate distinct consequences across neurons, microglia, astrocytes, oligodendrocyte-lineage cells, and neural stem or progenitor cells, and compare disease-specific patterns in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis/frontotemporal dementia, Huntington’s disease, and multiple sclerosis. These disorders exhibit overlapping but context-dependent autophagy–lysosomal defects, including impaired cargo recognition, mitochondrial turnover, autophagosome transport, lysosomal degradation, and cell-specific cargo processing. These mechanistic differences support defect-directed therapeutic strategies, although evidence that correcting individual bottlenecks restores autophagic flux and improves clinical outcomes remains limited. Upstream induction may be ineffective when downstream transport, fusion, or lysosomal degradation is impaired. Therapeutic strategies should therefore be evaluated using mechanism-appropriate measures of target engagement and downstream cargo degradation. Defining autophagic flux at cell- and compartment-specific resolution may help distinguish productive clearance from nonspecific pathway activation across disease stages, genotypes, and clinically distinct patient populations.

  • Open Access

    Fast-ripples are emergent properties of neuronal networks

    by Laurent Sheybani, Yichen Qiu, Prince Kumar Singh, Umesh Vivekananda, Neil Burgess, Beate Diehl, Andrew McEvoy, Anna Miserocchi, James A Bisby, Tawfeeq Shekh-Ahmad, et al.

    Fast-ripples (250-500 Hz) have been proposed as a promising biomarker in epilepsy, but their specificity remains unclear. In particular, it is uncertain whether they reflect chance coincident neural activity or distinctly generated pathological entities. We combined in silico simulations, neuronal cultures, the intra-hippocampal kainate rat model of hippocampal epilepsy, and human microwire recordings to investigate whether fast-ripples occur more frequently than expected by the chance aggregation of action potentials. Our simulations showed that chance aggregation can generate fast-ripples and that their incidence changes depending on brain state, an observation that we confirmed in our rodent data. The likelihood of exceeding chance depended on biological system complexity and vigilance state: fast-ripples in neuronal cultures did not surpass chance levels, whereas those in awake – but not sleeping – rodents did. Similarly, the incidence of fast-ripples in awake human recordings was ∼30% greater than expected by chance. As such, our findings suggest that most fast-ripples reflect stochastic network activity rather than distinctly generated pathological entities. This work does not rule out FRs as potential indicators of epileptogenic tissue, but it does challenge prevailing assumptions about their generation and specificity. Their higher prevalence in epileptogenic tissue is likely primarily due to increased excitation and/or neural synchronization, rather than peculiar abnormalities in network behavior.

  • Open Access

    CDDO-EA Attenuates Acute Seizures and Suppresses Post-Status Epilepticus Epileptogenesis

    by Yara Sheeni, Prince Kumar Singh, Shweta Maurya, Sereen Sandouka, Tawfeeq Shekh-Ahmad

    We aimed to investigate the acute anticonvulsant and long-term antiepileptogenic effects of the synthetic triterpenoid CDDO-EA in complementary experimental models of epilepsy. CDDO-EA was evaluated in the pentylenetetrazol seizure model and a kainic acid-induced post-status epilepticus model. Acute seizure severity, latency to generalized seizures, oxidative stress and inflammatory markers, spontaneous recurrent seizures, and hippocampal neuronal survival were assessed. In the pentylenetetrazol model, CDDO-EA pretreatment reduced maximal seizure severity and prolonged the latency to stage V-VI seizures. These effects were associated with decreased inflammatory cytokine levels and malondialdehyde levels, alongside increased superoxide dismutase and catalase activities 24 h after pentylenetetrazol administration. In the post-status epilepticus model, two weeks of CDDO-EA treatment significantly delayed the onset of spontaneous recurrent seizures and produced sustained reductions in weekly seizure frequency and cumulative seizure burden. Histological analysis demonstrated greater neuronal preservation in the hippocampal CA1 and CA3 regions of CDDO-EA-treated animals compared with vehicle controls. CDDO-EA exerts both anticonvulsant and disease-modifying effects by attenuating seizure severity, restoring redox-inflammatory homeostasis, preserving hippocampal neurons, and suppressing epileptogenesis after status epilepticus, supporting its therapeutic potential as a novel strategy for epilepsy.


  • Open Access

    Fast-ripples are emergent properties of neuronal networks

    by Laurent Sheybani, Yichen Qiu, Prince Kumar Singh, Umesh Vivekananda, Neil Burgess, Beate Diehl, Andrew McEvoy, Anna Miserocchi, James A Bisby, Tawfeeq Shekh-Ahmad, et al.

    Fast-ripples (250-500 Hz) have been proposed as a promising biomarker in epilepsy, but their specificity remains unclear. In particular, it is uncertain whether they reflect chance coincident neural activity or distinctly generated pathological entities. We combined in silico simulations, neuronal cultures, the intra-hippocampal kainate rat model of hippocampal epilepsy, and human microwire recordings to investigate whether fast-ripples occur more frequently than expected by the chance aggregation of action potentials. Our simulations showed that chance aggregation can generate fast-ripples and that their incidence changes depending on brain state, an observation that we confirmed in our rodent data. The likelihood of exceeding chance depended on biological system complexity and vigilance state: fast-ripples in neuronal cultures did not surpass chance levels, whereas those in awake – but not sleeping – rodents did. Similarly, the incidence of fast-ripples in awake human recordings was ∼30% greater than expected by chance. As such, our findings suggest that most fast-ripples reflect stochastic network activity rather than distinctly generated pathological entities. This work does not rule out FRs as potential indicators of epileptogenic tissue, but it does challenge prevailing assumptions about their generation and specificity. Their higher prevalence in epileptogenic tissue is likely primarily due to increased excitation and/or neural synchronization, rather than peculiar abnormalities in network behavior.

  • Open Access

    Activity-dependent antioxidant gene therapy protects against epileptogenesis

    by Prince Kumar Singh, Gabriele Lignani, Matthew C. Walker, Andreas Lieb, Tawfeeq Shekh-Ahmad


  • Open Access

    Targeting Hsp90 with cemdomespib reduces seizure burden and alters disease course in preclinical epilepsy models

    by Yara Sheeni, Prince Kumar Singh, Sereen Sandouka, Taige Zhang, Alina Nemirovski, Aseel Saadi, Rhoda Olowe Taiwo, Matthew C. Walker, Tawfeeq Shekh‐Ahmad

    Objective: Epilepsy is a chronic neurological disorder characterized by recurrent seizures and frequent cognitive and psychiatric comorbidities. Although current antiseizure medications provide symptomatic relief, they fail to prevent or modify epileptogenesis. Heat shock protein 90 (Hsp90) is increasingly recognized as a regulator of neuroinflammatory and oxidative stress pathways implicated in seizure generation and disease progression. Here, we investigated the therapeutic potential of cemdomespib, a novel and selective Hsp90 inhibitor, across complementary preclinical models of epilepsy. Methods: In vitro, cemdomespib was evaluated in the low‐magnesium model of epileptiform activity for its effects on neuronal calcium dynamics, mitochondrial membrane stability, and reactive oxygen species (ROS) generation. In vivo, acute seizure protection was assessed in the pentylenetetrazol (PTZ) model, and antiepileptogenic efficacy was tested in the kainic acid‐induced status epilepticus (KA‐SE) model using chronic video‐electrocorticographic recordings. Behavioral outcomes relevant to epilepsy‐associated comorbidities, including anxiety‐like behavior and exploratory activity, were also examined. Results: Cemdomespib reduced epileptiform calcium oscillations, stabilized mitochondrial membrane potential, and suppressed ROS generation in vitro. In the PTZ model, 45% of pretreated animals were protected from seizures, and those that seized exhibited reduced severity, shorter duration, and delayed onset. In the KA‐SE model, cemdomespib significantly mitigated the severity of SE and reduced the emergence of spontaneous recurrent seizures during the chronic phase, as evidenced by lower seizure frequency, decreased cumulative seizure burden, and prolonged latency to seizure onset. Furthermore, treated animals demonstrated improved anxiety‐like behavior and enhanced exploratory activity. Significance: Cemdomespib confers both acute seizure protection and long‐term suppression of epileptogenesis, likely through Hsp90‐dependent regulation of mitochondrial integrity and redox signaling. These findings highlight Hsp90 inhibition as a promising therapeutic strategy for seizure control while also mitigating the progression of epileptogenesis and its associated neurobehavioral impairments.


  • Open Access

    Selective inhibition of NOX2 after status epilepticus attenuates epileptogenesis and cognitive impairment: A sex-dependent study

    by Prince Kumar Singh, Shweta Maurya, Aseel Saadi, Taige Zhang, Andreas Lieb, Tawfeeq Shekh-Ahmad


  • Open Access

    Sex-Dependent Modulation of Nox2-Mediated Oxidative Stress in Epilepsy

    by Prince Kumar Singh, Shweta Maurya, Aseel Saadi, Taige Zhang, Andreas Lieb, Tawfeeq Shekh-Ahmad

    NOX2-driven reactive oxygen species mediated oxidative stress and neuroinflammation play a critical role in the pathophysiology of neurological disorders such as epilepsy. However, sex-dependent differences in the regulation of NOX2 associated oxidative stress and neuroinflammation and therapeutic targeting remain largely unexplored. Although various NOX inhibitors have been investigated, many have poor specificity, toxicity, and lack sustained efficacy. There is an urgent need for selective NOX2 inhibitors capable of mitigating oxidative stress and driven neuroinflammation while accounting for their sex-dependent responses. In this study, we investigated the therapeutic potential of GSK2795039, a selective NOX2 inhibitor, in reducing seizure burden, oxidative stress-mediated neuronal damage, and cognitive impairment in a sex-specific manner. GSK2795039 target NOX2 and associated oxidative stress-driven neuroinflammation efficiently in male over female rats following status epilepticus. However, males exhibited a more pronounced therapeutic response, with greater reductions in seizure and interictal spiking frequency, and neuronal loss, as well as improved cognitive outcomes. The comparatively weaker response in females suggests a reliance on alternative antioxidant and neuroprotective pathways. Our findings underscore the importance of considering sex as a biological variable in epilepsy treatment and highlight GSK2795039 as a promising NOX2-targeted therapy with differential efficacy based on sex-dependent redox homeostasis and inflammatory regulation.